Del Global Technologies of Valhalla, NY, reported strong growthin both revenues and earnings for fiscal 1996, thanks to a combinationof internal revenue growth and the addition of sales from x-rayvendor Gendex, which Del bought earlier this year (SCAN
Del Global Technologies of Valhalla, NY, reported strong growthin both revenues and earnings for fiscal 1996, thanks to a combinationof internal revenue growth and the addition of sales from x-rayvendor Gendex, which Del bought earlier this year (SCAN 12/27/95).
For the year (end-August), Del reported net sales of $43.7million, a company record and a figure that is 35% higher thanthe $32.6 million in revenues reported in fiscal 1995. Net incomewas $2.9 million, compared with $1.9 million in the prior year.
Del's revenues grew at an even greater rate in the fourth quarter,as the Gendex operations began contributing revenue in the middleof Del's third quarter. Del's revenues jumped 45% to $14.4 million,compared with $9.9 million in the fourth quarter of 1995. Netincome for the period was $970,000, compared with $427,000 inthe fourth quarter of 1995.
Medical imaging sales now contribute 59% of Del's revenues,according to chief executive Leonard Trugman. Del saw growth insales of power conversion subsystems for medical imaging applications,and the company's backlog stood at $23 million at year end, Trugmansaid. The company is planning to display a new neonatal imagingsystem at next month's Radiological Society of North America meeting.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.